AFT Pharmaceuticals Limited (NZE:AFT)

AFT Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, AFT Pharmaceuticals had annual revenue of 254.71M NZD with 22.44% growth. AFT Pharmaceuticals had revenue of 139.76M in the half year ending March 31, 2026, with 25.01% growth.

• Revenue: 254.71M
• Revenue Growth: +22.44%
• P/S Ratio: 1.62
• Revenue / Employee: 2.14M
• Employees: 119
• Market Cap: 412.12M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	254.71M	46.68M	22.44%
Mar 31, 2025	208.02M	12.61M	6.45%
Mar 31, 2024	195.41M	38.77M	24.75%
Mar 31, 2023	156.64M	26.33M	20.20%
Mar 31, 2022	130.31M	17.21M	15.22%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 31, 2026

Data Sources Report a data error